233 related articles for article (PubMed ID: 34257145)
1. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
2. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
4. A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
Goodman CW; Brett AS
JAMA Intern Med; 2019 May; 179(5):695-701. PubMed ID: 30907944
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Outpatient Gabapentinoid Prescribing for Pain.
Banks C; A Bowman L; Merrey J; Waldfogel JM
J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):143-147. PubMed ID: 36762999
[TBL] [Abstract][Full Text] [Related]
6. [Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?].
Echeverría Gorriti A; Alzueta Istúriz N; García González P; Fernández González J; Sanz Álvarez L; Garjón Parra J
Gac Sanit; 2023; 37():102283. PubMed ID: 36565565
[TBL] [Abstract][Full Text] [Related]
7. Opioid and gabapentinoid prescriptions in England from 2015 to 2020.
Xia Y; Forget P
PLoS One; 2022; 17(11):e0276867. PubMed ID: 36441772
[TBL] [Abstract][Full Text] [Related]
8. Gabapentinoid and Opioid Utilization and Cost Trends Among Injured Workers.
Liu C; Lavin RA; Yuspeh L; Leung N; Kalia N; Tsourmas NF; Williams L; Bernacki EJ; Tao XG
J Occup Environ Med; 2021 Feb; 63(2):e46-e52. PubMed ID: 33196519
[TBL] [Abstract][Full Text] [Related]
9. Gabapentinoid Prescribing Practices at a Large Academic Medical Center.
Huang LL; Wright JA; Fischer KM; Croghan IT; Nanda S; Schroeder DR; Vincent A
Mayo Clin Proc Innov Qual Outcomes; 2023 Feb; 7(1):58-68. PubMed ID: 36660177
[TBL] [Abstract][Full Text] [Related]
10. Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017.
Rahman A; Kane J; Montastruc F; Renoux C
Br J Clin Pharmacol; 2021 Aug; 87(8):3349-3353. PubMed ID: 33393673
[TBL] [Abstract][Full Text] [Related]
11. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
Waddy SP; Becerra AZ; Ward JB; Chan KE; Fwu CW; Eggers PW; Abbott KC; Kimmel PL
Am J Nephrol; 2020; 51(6):424-432. PubMed ID: 32428902
[TBL] [Abstract][Full Text] [Related]
12. Gabapentinoid Use in Perioperative Care and Current Controversies.
Patel AS; Abrecht CR; Urman RD
Curr Pain Headache Rep; 2022 Feb; 26(2):139-144. PubMed ID: 35084656
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin and pregabalin: do the benefits outweigh the harms?
Morrison EE; Sandilands EA; Webb DJ
J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
[TBL] [Abstract][Full Text] [Related]
14. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
15. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
Kaul I; Amin A; Rosenberg M; Rosenberg L; Meyer WJ
Burns; 2018 Mar; 44(2):414-422. PubMed ID: 28822592
[TBL] [Abstract][Full Text] [Related]
16. Gabapentinoid Prescribing for Carpal Tunnel Syndrome.
Billig JI; Gunaseelan V; Yazdanfar M; Sears ED; Iwashyna TJ; Chang T; Waljee JF
Hand (N Y); 2023 Jan; 18(1_suppl):106S-113S. PubMed ID: 35225033
[TBL] [Abstract][Full Text] [Related]
17. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Analysis of Gabapentinoid and Opioids to Opioid Monotherapy for Pain Relief in Patients with Chronic Neck and Low Back Pain.
Knezevic NN; Aijaz T; Camacho-Ortega A; Candido KD
Pain Med; 2021 Aug; 22(8):1760-1766. PubMed ID: 33502505
[TBL] [Abstract][Full Text] [Related]
19. Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021.
Chappuy M; Nourredine M; Clerc B; Fahmi M; Misslin P; Berthier M; Laloi L; Rolland B
Fundam Clin Pharmacol; 2022 Apr; 36(2):448-452. PubMed ID: 34498306
[TBL] [Abstract][Full Text] [Related]
20. Fatalities associated with gabapentinoids in England (2004-2020).
Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
